Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown…

Recall date

January 27, 2017

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0493-2017

FDA classification

Class II

Brand / firm

Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Sold / distributed

Nationwide

Why it was recalled

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20